|
OMIM |
Link |
Information gain |
01 |
|
polycystic kidneys
|
[NCBI]
|
0.0194366
|
|
|
renal-hepatic-pancreatic dysplasia with dandy-walker cyst
|
[NCBI]
|
0.0025036
|
|
|
MRD
|
[NCBI]
|
0.00237038
|
|
|
MKS1
|
[NCBI]
|
0.00210221
|
|
|
arima syndrome
|
[NCBI]
|
0.00202651
|
|
|
ARPKD
|
[NCBI]
|
0.00191152
|
|
|
PKD1
|
[NCBI]
|
0.00150798
|
|
|
campomelia, cumming type
|
[NCBI]
|
0.00146205
|
|
|
vertebral ossification, defect in, with nephrogenic rests
|
[NCBI]
|
0.000945056
|
|
|
VUR1
|
[NCBI]
|
0.000809805
|
|
|
ATD1
|
[NCBI]
|
0.000695093
|
|
|
PKD2
|
[NCBI]
|
0.000602259
|
|
|
genitopatellar syndrome
|
[NCBI]
|
0.000592537
|
|
|
SLE
|
[NCBI]
|
0.000588031
|
|
|
MKS2
|
[NCBI]
|
0.000521908
|
|
|
short rib-polydactyly syndrome, type i
|
[NCBI]
|
0.000495958
|
|
|
OFD4
|
[NCBI]
|
0.000421973
|
|
|
acroosteolysis with osteoporosis and changes in skull and mandible
|
[NCBI]
|
0.00038357
|
|
|
CF
|
[NCBI]
|
0.000377455
|
|
|
lymphedema, microcephaly, chorioretinopathy syndrome
|
[NCBI]
|
0.000362597
|
|
|
short rib-polydactyly syndrome, type ii
|
[NCBI]
|
0.000362597
|
|
|
OFD1
|
[NCBI]
|
0.000299178
|
|
|
PKD3
|
[NCBI]
|
0.000246824
|
|
|
TS
|
[NCBI]
|
0.000232247
|
|
|
cerebellar vermis aplasia with associated features suggesting smith-lemli-opitz syndrome and meckel syndrome
|
[NCBI]
|
0.00021216
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.000210932
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
0.000207737
|
|
|
serpentine fibula-polycystic kidney syndrome
|
[NCBI]
|
0.000174114
|
|
|
PCLD
|
[NCBI]
|
0.000173463
|
|
|
TTC10
|
[NCBI]
|
0.000150508
|
|
|
glomerulocystic kidney disease with hyperuricemia and isosthenuria
|
[NCBI]
|
0.000146786
|
|
|
CXORF5
|
[NCBI]
|
0.00014674
|
|
|
SLC39A7
|
[NCBI]
|
0.000138194
|
|
|
CDC5L
|
[NCBI]
|
0.000119221
|
|
|
HNF1B
|
[NCBI]
|
0.000119056
|
|
|
ZS
|
[NCBI]
|
0.000115287
|
|
|
NPHP1
|
[NCBI]
|
0.0001103
|
|
|
MADD
|
[NCBI]
|
0.000107133
|
|
|
NPHP3
|
[NCBI]
|
0.000100864
|
|
|
PGP
|
[NCBI]
|
0.000100267
|
|
|
ETFDH
|
[NCBI]
|
0.000100267
|
|
|
USF2
|
[NCBI]
|
9.66107e-05
|
|
|
EGF
|
[NCBI]
|
8.90911e-05
|
|
|
goiter, multinodular, cystic renal disease and digital anomalies
|
[NCBI]
|
8.88147e-05
|
|
|
PKHD1
|
[NCBI]
|
7.84006e-05
|
|
|
BBS
|
[NCBI]
|
7.53104e-05
|
|
|
MEP1A
|
[NCBI]
|
6.90613e-05
|
|
|
polycystin 1-like 3
|
[NCBI]
|
6.90613e-05
|
|
|
NOMO3
|
[NCBI]
|
6.90613e-05
|
|
|
HSD17B8
|
[NCBI]
|
6.90613e-05
|
|
|
rgs16-interacting membrane protein
|
[NCBI]
|
6.90613e-05
|
|
|
NOMO1
|
[NCBI]
|
6.90613e-05
|
|
|
MKRN1
|
[NCBI]
|
6.90613e-05
|
|
|
PTER
|
[NCBI]
|
6.90613e-05
|
|
|
NOMO2
|
[NCBI]
|
6.90613e-05
|
|
|
AQP11
|
[NCBI]
|
6.90613e-05
|
|
|
AQP12A
|
[NCBI]
|
6.90613e-05
|
|
|
PKD1L1
|
[NCBI]
|
6.90613e-05
|
|
|
axial osteomalacia
|
[NCBI]
|
6.64098e-05
|
|
|
renal dysplasia, diffuse cystic
|
[NCBI]
|
6.64098e-05
|
|
|
NEK1
|
[NCBI]
|
5.79953e-05
|
|
|
ATP6V0C
|
[NCBI]
|
5.52901e-05
|
|
|
CIAPIN1
|
[NCBI]
|
5.52901e-05
|
|
|
CLDN19
|
[NCBI]
|
5.52901e-05
|
|
|
KIF3A
|
[NCBI]
|
5.52901e-05
|
|
|
TNS1
|
[NCBI]
|
5.52901e-05
|
|
|
XYLT2
|
[NCBI]
|
5.52901e-05
|
|
|
polycystin 1-like 2
|
[NCBI]
|
5.52901e-05
|
|
|
SET
|
[NCBI]
|
5.52901e-05
|
|
|
PKDTS
|
[NCBI]
|
5.25547e-05
|
|
|
MKS1
|
[NCBI]
|
5.00981e-05
|
|
|
PRKCSH
|
[NCBI]
|
5.00981e-05
|
|
|
osteomesopyknosis
|
[NCBI]
|
4.85265e-05
|
|
|
PKD2L1
|
[NCBI]
|
4.67298e-05
|
|
|
chorioretinal dysplasia-microcephaly-mental retardation syndrome
|
[NCBI]
|
4.53301e-05
|
|
|
VEGF
|
[NCBI]
|
4.52798e-05
|
|
|
NPHP3
|
[NCBI]
|
4.22355e-05
|
|
|
HAX1
|
[NCBI]
|
4.22355e-05
|
|
|
GFER
|
[NCBI]
|
3.91651e-05
|
|
|
FRAP1
|
[NCBI]
|
3.61023e-05
|
|
|
ADAM17
|
[NCBI]
|
3.413e-05
|
|
|
AVP
|
[NCBI]
|
3.35274e-05
|
|
|
ANXA5
|
[NCBI]
|
3.33741e-05
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
3.24775e-05
|
|
|
hyperprolinemia, type i
|
[NCBI]
|
3.24775e-05
|
|
|
CD2AP
|
[NCBI]
|
3.20193e-05
|
|
|
SOCS1
|
[NCBI]
|
2.83804e-05
|
|
|
PAX2
|
[NCBI]
|
2.83804e-05
|
|
|
MVA
|
[NCBI]
|
2.73596e-05
|
|
|
AGT
|
[NCBI]
|
2.45281e-05
|
|
|
CTNNB1
|
[NCBI]
|
2.3704e-05
|
|
|
SLSN1
|
[NCBI]
|
2.36235e-05
|
|
|
MNS
|
[NCBI]
|
2.36235e-05
|
|
|
refsum disease, infantile form
|
[NCBI]
|
2.12415e-05
|
|
|
BCL2
|
[NCBI]
|
2.07992e-05
|
|
|
GPT
|
[NCBI]
|
2.00648e-05
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
1.92333e-05
|
|
|
VHL
|
[NCBI]
|
1.89994e-05
|
|
|
HS
|
[NCBI]
|
1.83108e-05
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
1.79156e-05
|
|
|
TSC2
|
[NCBI]
|
1.76163e-05
|
|
|
RCDP1
|
[NCBI]
|
1.67284e-05
|
|
|
NPPA
|
[NCBI]
|
1.66051e-05
|
|
|
VIM
|
[NCBI]
|
1.64915e-05
|
|
|
EVC
|
[NCBI]
|
1.59991e-05
|
|
|
EPO
|
[NCBI]
|
1.35318e-05
|
|
|
AFP
|
[NCBI]
|
1.26362e-05
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
1.19196e-05
|
|
|
CFTR
|
[NCBI]
|
1.17841e-05
|
|
|
RCC1
|
[NCBI]
|
1.03649e-05
|
|
|
ALGS1
|
[NCBI]
|
8.5242e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
7.86977e-06
|
|
|
SLOS
|
[NCBI]
|
7.6654e-06
|
|
|
HGF
|
[NCBI]
|
6.12475e-06
|
|
|
HHT
|
[NCBI]
|
5.55718e-06
|
|
|
HP
|
[NCBI]
|
4.96806e-06
|
|
|
GFAP
|
[NCBI]
|
3.58047e-06
|
|
|
ALD
|
[NCBI]
|
3.32662e-06
|
|
|
APOE
|
[NCBI]
|
2.51653e-06
|
|
|
EGFR
|
[NCBI]
|
8.3372e-07
|
|
|
BWS
|
[NCBI]
|
6.78586e-07
|
|
|
PCNA
|
[NCBI]
|
3.92261e-07
|
|
|
WBS
|
[NCBI]
|
2.60541e-07
|
|
|
PTH
|
[NCBI]
|
1.07656e-07
|
|
|
MODY
|
[NCBI]
|
8.23868e-08
|
|
|
PJS
|
[NCBI]
|
5.57906e-08
|
|